Medtronic plc (FRA:2M6)
Germany · Delayed Price · Currency is EUR | Market Cap | 102.74B |
| Revenue (ttm) | 29.14B |
| Net Income (ttm) | 3.97B |
| Shares Out | n/a |
| EPS (ttm) | 3.08 |
| PE Ratio | 25.88 |
| Forward PE | 16.40 |
| Dividend | 2.54 (3.14%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | n/a |
| Average Volume | 686 |
| Open | 79.92 |
| Previous Close | 80.07 |
| Day's Range | 79.92 - 79.92 |
| 52-Week Range | 68.50 - 90.89 |
| Beta | n/a |
| RSI | 51.21 |
| Earnings Date | Nov 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of...
Medtronic: FY26 Outlook Strengthened By New Product Launches
Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...
Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Meet the Father and Daughter Tracking Heartbeats of the Wild
In a world of shrinking wilderness and rising uncertainty, Tim and Noelle Laske of Medtronic find meaning in tracking the invisible signals of life in the most remote corners of Earth. NORTHAMPTON, MA...
1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today
Medtronic is one of the largest medical device makers in the world, and it is focused on getting more profitable.
Medtronic (MDT) Shares Cross 3% Yield Mark
Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Medtronic PLC (Symbol: MDT) were yielding above the 3% mark based on its quarterly dividend (annualized ...
FDA Greenlights Medtronic's (MDT) Bladder Control Device
FDA Greenlights Medtronic's (MDT) Bladder Control Device
Strategy To YieldBoost Medtronic To 9.9% Using Options
Shareholders of Medtronic PLC (Symbol: MDT) looking to boost their income beyond the stock's 3% annualized dividend yield can sell the March 2026 covered call at the $100 strike and collect the premiu...
Medtronic gets FDA nod for the Altaviva device
Medtronic’s Altaviva bladder control device earns FDA approval for urge urinary incontinence. Read more here.
Medtronic (MDT) Gains FDA Approval for Altaviva Device
Medtronic (MDT) Gains FDA Approval for Altaviva Device
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir...
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MDT Factor-Based Stock Analysis
Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Smart Money Is Betting Big In MDT Options
Financial giants have made a conspicuous bullish move on Medtronic. Our analysis of options history for Medtronic (NYSE: MDT) revealed 12 unusual trades. Delving into the details, we found 41% of tra...
Potential CMS Policy Update Could Boost Medtronic (MDT) Adoption
Potential CMS Policy Update Could Boost Medtronic (MDT) Adoption
Medtronic: Buy This Dividend Aristocrat While It's Good Value
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Medtronic plc (MDT) Announces Pricing of New Senior Notes Offering
Medtronic plc (MDT) Announces Pricing of New Senior Notes Offering
Medtronic (MDT) Announces â¬1.5 Billion Senior Notes Offering
Medtronic (MDT) Announces â¬1.5 Billion Senior Notes Offering
Medtronic prices $1.5 billion senior notes
Medtronic Prices EUR 1.5 Bln In Senior Notes Due 2030 And 2045
(RTTNews) - Medtronic plc (MDT) announced that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering of 750 million euros principal amount of 2.950% senior notes due 2030 and 7...
Medtronic (MDT) Prices â¬1.5 Billion Senior Notes for Debt Repayment
Medtronic (MDT) Prices â¬1.5 Billion Senior Notes for Debt Repayment
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
GALWAY , Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Of...
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
GALWAY, Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offe...